Loading...

Home
ETF
QNCX

QNCX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

QNCX News

Quince Therapeutics Acquires Orphai Therapeutics to Expand Pipeline

May 18 2026seekingalpha

LAM-001 Shows Significant Efficacy in PH-ILD Patients

May 18 2026Globenewswire

LAM-001 Shows Significant Efficacy in PH-ILD Patients

May 18 2026Newsfilter

Quince Acquires Orphai to Advance LAM-001 Development

May 18 2026Globenewswire

LAM-001 Shows Significant Efficacy in PH-ILD Patients

May 18 2026Globenewswire

Quince Acquires Orphai to Advance Pulmonary Disease Treatments

May 18 2026Newsfilter

Quince Therapeutics Releases Phase 2a Data for LAM-001 in PH-ILD Patients

May 18 2026Newsfilter

Quince Therapeutics Settles Debt Obligations, Shares Rise

Mar 30 2026NASDAQ.COM

Quince Therapeutics Settles Debt to Enhance Strategic Flexibility

Mar 30 2026seekingalpha

Quince Therapeutics Shares Surge 40% After Debt Settlement Announcement

Mar 30 2026stocktwits

Quince Therapeutics Settles Debt Obligations with EIB

Mar 30 2026Newsfilter

Quince Therapeutics Resolves EIB Loan Responsibilities for $5.5 Million, According to SEC Filing

Mar 30 2026moomoo

Quince Therapeutics Shares Surge After Hours Despite Major Losses

Feb 13 2026Benzinga

Quince Therapeutics Stock Plummets 52% Amid Financial Struggles

Feb 12 2026Benzinga

U.S. Stocks Mostly Higher in Morning Trade, Dow Up Over 200 Points

Feb 12 2026Benzinga

Quince Therapeutics Shares Surge on Strategic Review Announcement

Feb 11 2026Benzinga